Talik Tahmasian, - Pharmacist in Sunland, CA

Talik Tahmasian, is a Pharmacist based in Sunland, California. Talik Tahmasian is licensed to practice in California (license number 77895) and her current practice location is 10465 Sunland Blvd, Sunland, California. She can be reached at her office (for appointments etc.) via phone at (818) 352-4129.

NPI number for Talik Tahmasian is 1588179428 and her current mailing address is 7223 Apperson St Unit 111, Tujunga, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1588179428.

Contact Information

Talik Tahmasian,
10465 Sunland Blvd,
Sunland, CA 91040-1905
(818) 352-4129
Not Available

Healthcare Provider's Profile

Full NameTalik Tahmasian
GenderFemale
SpecialityPharmacist
Location10465 Sunland Blvd, Sunland, California
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1588179428
  • Provider Enumeration Date: 12/13/2017
  • Last Update Date: 12/13/2017

Medical Identifiers

Medical identifiers for Talik Tahmasian such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1588179428NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 77895 (California)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Talik Tahmasian is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Talik Tahmasian,
7223 Apperson St Unit 111,
Tujunga, CA 91042-1877

Ph: (818) 618-6488
Talik Tahmasian,
10465 Sunland Blvd,
Sunland, CA 91040-1905

Ph: (818) 352-4129

News Archive

USPTO issues Cardio3 BioSciences Notice of Allowance for patent covering CAR-expressing TCR-deficient T-Cells

Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.

Cancer patients more likely to die from heart disease, stroke, study found

Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.

Clearing toxins in the brains of Alzheimer's patients can stave off future reductions in cognitive abilities

The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.

Intellipharmaceutics granted extension of deadline to regain compliance with Nasdaq Listing Rule

Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, today announced that the staff of the Nasdaq Stock Market has granted the Company an extension of the deadline to regain compliance with Nasdaq Listing Rule 5550(b).

Read more News

› Verified 9 days ago


Pharmacist in Sunland, CA

Armineh Gasparian, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 10050 La Canada Way, Sunland, CA 91040
Phone: 818-307-0454    
Sana Fazai, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 10465 Sunland Blvd, Sunland, CA 91040
Phone: 818-352-4129    
Klarinda Barkhordarian Boghosian, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 11000 Scoville Ave, Sunland, CA 91040
Phone: 818-489-7846    
Dr. Crisanto Ortiz Ortiz-luis, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 8341 Jayseel St, Sunland, CA 91040
Phone: 818-293-1949    
Rajya Lakshmi Meka, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 10465 Sunland Blvd, Sunland, CA 91040
Phone: 818-352-4129    
Karina Keshishian, PHARM. D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 8441 Foothill Blvd, Sunland, CA 91040
Phone: 818-925-1321    Fax: 818-446-2241

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.